Clinical Trials List
Protocol NumberMOST107-2314-B-182A-059-MY2
Not yet recruiting
2020-10-01 - 2021-01-17
Phase II
Recruiting3
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 葉智華 Division of Radiology
- Hung-Ming Wang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- 林倩伃 Division of Radiation Therapy
- 廖俊達 Division of Otolaryngology
- 鄭乃銘 Division of Nuclear Medicine
- Gigin Lin Division of Radiology
- 林育駿放射師 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
Co-Principal Investigator
- Sheng-Chieh Chan Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
0 participants
